Trials / Recruiting
RecruitingNCT07008183
Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes
Perinatal Thymic Dysregulation: Characterization of Perinatal Mood Episodes
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Centre Hospitalier Charles Perrens, Bordeaux · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The perinatal period is recognized as a time of heightened psychological vulnerability. This research aims to improve the diagnosis and therapeutic management of mood episodes occurring during this time. It is integrated into routine clinical care and seeks to standardize the evaluation of criteria used to characterize mood episodes, while also exploring relevant contextual factors. Traditionally, clinical attention has focused on postnatal depression; however, increasing evidence highlights the presence of hypomanic symptoms-such as distractibility, reduced need for sleep, tachypsychia, and irritability-during the postpartum period. These symptoms may coexist with depressive features, resulting in complex clinical presentations that are often difficult to recognize and manage. Consequently, many cases go undiagnosed and untreated. Current research has largely concentrated on depressive episodes (perinatal depression), with less emphasis on manic, hypomanic, or mixed episodes indicative of bipolar disorder. A systematic evaluation of hypomanic symptoms occurring alongside depressive symptoms in the postpartum period could refine clinical diagnosis and support more targeted and effective therapeutic interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | self-questionnaires | Patients who volunteer to take part in the research will complete self-questionnaires before their appointment with the psychiatrist. |
Timeline
- Start date
- 2025-10-13
- Primary completion
- 2026-07-31
- Completion
- 2026-12-31
- First posted
- 2025-06-06
- Last updated
- 2025-12-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07008183. Inclusion in this directory is not an endorsement.